177 material Form 8-K filings that 165 companies we cover made with the SEC in April 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Banner Corporation reported first-quarter 2024 net income of $37.6 million, or $1.09 per diluted share, down from $42.6 million ($1.24) in the preceding quarter and $55.6 million ($1.61) a year earlier. Higher funding costs reduced net interest income to $133.0 million, and the board declared a regular $0.48 per share dividend. The filing does not include an updated outlook, and the lower per-share earnings are the key takeaway for shareholders.
Net income was $37.6 million, or $1.09 per diluted share, versus $42.6 million ($1.24) in the preceding quarter and $55.6 million ($1.61) in the first quarter of 2023.
Revenues were $144.6 million, compared with $152.5 million in the preceding quarter and $162.6 million a year earlier.
Net interest margin was 3.74%, down from 3.83% in the preceding quarter, as total deposit costs rose to 1.37% from 1.18%.
A regular quarterly cash dividend of $0.48 per share is payable May 10, 2024, to holders of record on April 30, 2024.
Equifax reported first-quarter 2024 revenue of $1.389 billion, up 7%, and net income attributable to Equifax of $124.9 million, up 11%, with diluted EPS of $1.00 versus $0.91 a year earlier. The company kept its full-year 2024 guidance, with revenue midpoint of $5.720 billion and Adjusted EPS of $7.35, while citing an expected 11% decline in U.S. mortgage credit inquiries for the year.
Q1 2024 revenue of $1.389 billion, up 7%; Workforce Solutions up 1%, USIS up 10%, International up 13%
Net income attributable to Equifax of $124.9 million, up 11%; diluted EPS $1.00 vs. $0.91; Adjusted EPS $1.50, up 5%
Monarch Casino & Resort reported first-quarter 2024 net revenue of $121.7 million, up 4.3%, and net income of $18.3 million, up 3.4%, both described by the company as first-quarter records. The company also declared a $0.30 per share cash dividend payable June 15, 2024, to holders of record on June 1, 2024, which is part of a previously announced $1.20 annual dividend.
Net revenue was $121.7 million, up 4.3% from $116.6 million a year earlier; net income was $18.3 million, up 3.4%.
Diluted EPS was $0.93, up from $0.90 in the first quarter of 2023, an increase of 3.3%.
Adjusted EBITDA was $38.5 million, up 5.7%, and the adjusted EBITDA margin was 31.7% versus 31.3% a year earlier.
Quarterly cash dividend of $0.30 per share is payable June 15, 2024, to stockholders of record on June 1, 2024.
Triumph Financial reported first-quarter 2024 net income to common stockholders of $3.4 million, or $0.14 per diluted share, down from $0.37 in the fourth quarter of 2023 and $0.43 in the first quarter of 2023. The company attributed the decline to a soft freight market, a $5.9 million drop in net interest income, nearly $6 million of credit costs, and higher expenses tied to technology investments, and it expects second-quarter noninterest expense in a $92 million to $94 million range.
Q1 2024 net income to common stockholders was $3.4 million, or $0.14 per diluted share, versus $8.8 million, or $0.37, in Q4 2023 and $10.2 million, or $0.43, in Q1 2023.
Return on average assets was 0.31% in Q1 2024, compared with 0.70% in Q4 2023 and 0.84% in Q1 2023.
Total credit expense was just under $6 million, and net interest income fell $5.9 million from the prior quarter.
Second-quarter noninterest expense is likely to be in the $92 million to $94 million range, according to the letter.
Kinder Morgan reported first-quarter 2024 EPS of $0.33, up 10% from a year earlier, and net income attributable to KMI of $746 million, up from $679 million. Revenues were $3,842 million, slightly below $3,888 million in the first quarter of 2023. The board approved a quarterly dividend of $0.2875 per share, and management said there is no change to its full-year 2024 budget guidance.
Q1 2024 EPS was $0.33, up 10%; DCF per share was $0.64, up 5%.
Net income attributable to KMI was $746 million, compared with $679 million in Q1 2023.
Revenues were $3,842 million, compared with $3,888 million in Q1 2023.
Dividend of $0.2875 per share is payable May 15, 2024, to holders of record on April 30, 2024; 2024 budget guidance is unchanged.
Winmark reported first-quarter 2024 net income of $8.8 million, or $2.41 per diluted share, down from $8.9 million, or $2.49 per diluted share, a year earlier. Revenue fell to $20.1 million from $20.5 million, and the company said results were affected by its May 2021 decision to run off its leasing portfolio. The board also approved a quarterly dividend of $0.90 per share, an increase of $0.10, payable June 3, 2024 to holders of record on May 15, 2024.
Q1 2024 net income was $8.8 million, or $2.41 per diluted share, versus $8.9 million, or $2.49, in Q1 2023
Total revenue was $20.1 million versus $20.5 million a year earlier; leasing income fell to $836,800 from $1.6 million
Quarterly dividend raised to $0.90 per share, up $0.10 from the prior rate; payable June 3, 2024
Dividend record date is May 15, 2024; future dividends remain subject to board approval
VITAS Healthcare, a wholly owned subsidiary of Chemed, completed its $85 million purchase of substantially all hospice operations and an assisted living facility from Covenant Health and Community Services, effective April 17, 2024. The purchase was made with cash on hand, and the filing does not report financial results from the acquired operations.
Purchase price: $85 million, structured as an asset purchase, funded with cash on hand
Covenant hospice operations span the Florida panhandle and Alabama, including Pensacola, Tallahassee, Panama City and Dothan markets
Transaction was first announced on March 13, 2024 and closed effective April 17, 2024
Corcept Therapeutics entered into a sublease on April 12, 2024 for about 50,632 rentable square feet at 101 Redwood Shores Parkway in Redwood City, California, with the sublessor Zuora, Inc. The lease runs from about July 1, 2024 through June 30, 2030, creating a new direct financial obligation. The filing discloses base rent averaging $1.4 million a year plus $240,000 a year for shared amenities, a modest commitment that the filing does not compare with Corcept's financial results.
Sublease dated April 12, 2024 with Zuora, Inc. for about 50,632 rentable square feet
Term expected to start on or around July 1, 2024 and end June 30, 2030
Base rent averages $1.4 million annually, plus $240,000 annually for shared amenities space
Full sublease to be filed with a Form 10-Q; Corcept intends to seek confidential treatment for some terms
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.